Dr Lip Lee is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust and also see patients privately. He also holds the positions of Radiotherapy Quality Assurance Clinical Lead and Educational Supervisor.

Dr Lee specialises in head and neck, lung, oesophageal and skin cancer. He graduated from the University of Melbourne, Australia in 1997, and then undertook general medical training in the UK. Dr Lee began working in oncology at the Christie in 2000, after completing his MRCP. During his training at the Christie, Dr Lee also visited the MD Anderson cancer centre and William Beaumont Hospital Maryland Proton Treatment Centre in the USA to develop further specific technical skills in IMRT, SABR and Protons.

He is one of the clinical leads who developed stereotactic lung radiotherapy for lung cancer for the first time in the North West, and proton therapy in head and neck patients, in addition to being involved with new developments in VMAT (Volumetric Modulated Arc Therapy) for head and neck and lung cancers. He was also on the examination panel for Royal College of Radiologists, UK, and was the previous Training Programme Director for the oncology training in the North West Region. He is currenlty the ClinicaL Director for Clinical Oncology & Radiotherapy services.

Dr Lee's research interests include intensity modulated radiotherapy (IMRT) treatment for head and neck cancer, image guided radiotherapy (IGRT), novel targeted agents for head and neck cancer including monoclonal antibodies, immunomodulators, immunotherapy and live virus.

• Radiotherapy
• Chemotherapy
• Immunotherapy

• Head & Neck Cancers
• Lung Cancer
• Oesophageal Cancer
• Skin Cancer